Serigne Lo

15.5k citations
281 papers · 6.2k · 1 hit paper · h-index 39

Impact in

  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • Cutaneous Melanoma Detection and Management
    • CAR-T cell therapy research
  • Nephrology top 0.5%
    • Acute Kidney Injury Research

Papers in

    • Cutaneous Melanoma Detection and Management 100
    • Cancer Immunotherapy and Biomarkers 51
    • CAR-T cell therapy research 31
    • Melanoma and MAPK Pathways 42

Serigne Lo

258 papers receiving 6.1k citations

Serigne Lo's Hit Papers

Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study 2018 · 666 citations
6660+2+5Years since publication200400600

Peers

Serigne Lo
Comparison fields: 5 of 166
  • Oncology 2.7k
  • Nephrology 628
  • Critical Care and Intensive Care Medicine 197
  • Pulmonary and Respiratory Medicine 1.0k
  • Immunology 687
Replace Takuhiro Yamaguchi with:
Takuhiro Yamaguchi Japan
Hajime Uno United States
Colin A. Graham Hong Kong
Marta Fiocco Netherlands
Julio Núñez Spain
Matthew J. Maurer United States
Brian L. Egleston United States
Alexander Strasak Austria
Claudia Schmoor Germany
Madhu Mazumdar United States
Serigne Lo relative to Takuhiro Yamaguchi Japan Takuhiro Yamaguchi's profile →
Citations per field
00.5×3.8×
Takuhiro Yamaguchi · 1×
Citations per year

Countries citing papers authored by Serigne Lo

Since Specialization
Citations

This map shows the geographic impact of Serigne Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serigne Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serigne Lo more than expected).

Fields of papers citing papers by Serigne Lo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serigne Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serigne Lo. The network helps show where Serigne Lo may publish in the future.

Co-authors

The 25 scholars most cited alongside Serigne Lo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Serigne Lo Line = papers co-authored together Serigne Lo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 281 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
Hit paper breakdown →
2018666
2 2017238
3 2018230
4 2017196
5 2013178
6 2021148
7 2016129
8 2015124
9 2014120
10 2018116
11 2014110
12 2019108
13 2018104
14 2013103
15 2020100
16 201587
17 201785
18 201384
19 201781
20 201878

About Serigne Lo

Serigne Lo is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Epidemiology, having authored 281 papers that have together received 6.2k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (100 papers), Cancer Immunotherapy and Biomarkers (51 papers), Melanoma and MAPK Pathways (42 papers), CAR-T cell therapy research (31 papers), Brain Metastases and Treatment (18 papers), Immunotherapy and Immune Responses (17 papers), Cancer Genomics and Diagnostics (13 papers) and Nonmelanoma Skin Cancer Studies (12 papers). The work is most often cited by research in Oncology (2.7k citations), Nephrology (628 citations), Critical Care and Intensive Care Medicine (197 citations), Pulmonary and Respiratory Medicine (1.0k citations) and Immunology (687 citations). Serigne Lo has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Richard A. Scolyer, Georgina V. Long, Alexander M. Menzies, Matteo S. Carlino, Alexander Guminski, John F. Thompson, Maria Gonzalez, James S. Wilmott, Shahneen Sandhu and Grant A. McArthur. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Annals of Surgical Oncology, European Journal of Cancer and British Journal of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact